To access this element change to forms mode OFF
Grant Award View - GA218142
Pathway to use of immunotherapy in clinical practice for type 1 diabetes
GA ID:
GA218142
Agency:
Department of Health and Aged Care
Approval Date:
4-Nov-2021
Publish Date:
16-Feb-2022
Category:
Medical Research
Grant Term:
14-Feb-2022 to 12-Apr-2027
Value (AUD):
$2,943,600.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 21/22 Health Policy Research and Analysis
Grant Program:
Medical Research Future Fund
Grant Activity:
Pathway to use of immunotherapy in clinical practice for type 1 diabetes
Purpose:
A grant has been awarded to ST. VINCENT'S INSTITUTE OF MEDICAL RESEARCH to address Type 1 diabetes (T1D) challenges such as better biomarkers, education and change within the workforce, and meeting the requirements of the TGA. The grantee will provide centralised expert advice on immunotherapy for patients and clinicians across MACH-based hospitals.
GO ID:
GO Title:
MRFF 2020 Rapid Applied Research Translation Grant Opportunity
Internal Reference ID:
RARUR000103
Selection Process:
Open Competitive
Confidentiality - Contract:
No
Confidentiality - Outputs:
No
Grant Recipient Details
Recipient Name:
ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH
Recipient ABN:
52 004 705 640
Grant Recipient Location
Suburb:
FITZROY
Town/City:
FITZROY
Postcode:
3065
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
3065
Country:
AUSTRALIA